Jane Street Group, LLC Fennec Pharmaceuticals Inc. Transaction History

Jane Street Group, LLC

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	SELL	$4.85 - $6.73 $2,255 - $3,129	-465 Reduced 2.35%	19,339 $96,000
Q2 2024 Aug 14, 2024	BUY	$6.02 - $10.99 $25,585 - $46,707	4,250 Added 27.32%	19,804 $121,000
Q1 2024 May 15, 2024	BUY	$8.82 - $11.12 $137,186 - $172,960	15,554 New	15,554 $172,000
Q1 2023 May 15, 2023	BUY	$7.38 - $10.35 $460,320 - $645,570	62,374 Added 241.14%	88,240 $734,000
Q4 2022 Feb 14, 2023	BUY	$7.63 - $10.22 $86,669 - $116,088	11,359 Added 78.3%	25,866 $248,000
Q3 2022 Nov 14, 2022	BUY	$5.71 - $8.54 $82,834 - $123,889	14,507 New	14,507 $118,000
Q3 2021 Nov 16, 2021	SELL	$6.51 - $9.62 $158,049 - $233,554	-24,278 Closed	0 $0
Q2 2021 Aug 16, 2021	BUY	$5.96 - $7.85 $144,696 - $190,582	24,278 New	24,278 $177,000
Q3 2020 Nov 17, 2020	SELL	$5.19 - $10.17 $103,260 - $202,342	-19,896 Closed	0 $0
Q2 2020 Aug 17, 2020	BUY	$5.43 - $9.39 $108,035 - $186,823	19,896 New	19,896 $166,000

14.7M

10K

83.8K

Ticker FENC
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 26,067,300
Market Cap $170M
Description
Fennec Pharmaceuticals Inc. operates as a biopharmaceutical company. Its product candidate in the clinical stage of development is PEDMARK, a formulation of sodium thiosulfate for the prevention of platinum-induced ototoxicity in pediatric cancer patients. The company was formerly known as Adherex Technologies Inc. and changed its name to Fennec...

Get notified when there are updates to the investment portfolio of Jane Street Group, LLC, based on Form 13F filings with the SEC.

Stay updated on Jane Street Group, LLC with notifications on news.